Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFRESH: Foligraf vs Gonal-f in ART
NCT05266924Phase 3Unknown
- Sponsor
- Bharat Serums and Vaccines
- Start
- Jul 2022
- Primary completion
- Aug 2023
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Foligraf in female infertility (2 arms), sponsored by Bharat Serums and Vaccines. Primary endpoint: Number of oocytes retrieved. Status: unknown.
02
Drugs
Foligraf
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT05266924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266924.